08.06.2021 21:09:00

Moore Kuehn Encourages USCR, QTS, CNST and ESXB Investors to Contact Law Firm

NEW YORK, June 8, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.  Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:

(PRNewsfoto/Moore Kuehn, PLLC)

  • U.S. Concrete, Inc. (NASDAQ: USCR)

U.S. Concrete has agreed to merge with Vulcan Materials Company. Under the proposed transaction, U.S. Concrete shareholders will receive $74.00 in cash per share.

  • QTS Realty Trust (NYSE: QTS)

QTS Realty Trust has agreed to merge with Blackstone Group. Under the proposed transaction, QTS shareholders will receive $78.00 in cash per share. 

  • Constellation Pharmaceuticals, Inc. (NASDAQ: CNST)

Constellation Pharmaceuticals has agreed to merge with MorphoSys AG. Under the proposed transaction, Constellation shareholders will receive $34.00 in cash per share.

  • Community Bankers Trust Corporation (NASDAQ: ESXB)

Community Bankers Trust has agreed to merge with United Bankshares. Under the proposed transaction, Community Bankers shareholders will receive 0.3173 shares of United Bankshares common stock per share.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process. 

Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com or telephone at (212) 709-8245.  The consultation and case are free with no obligation to you.  Moore Kuehn pays all case costs and does not charge its investor clients.Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

Moore Kuehn is a 5-star Google rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims.  For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
jkuehn@moorekuehn.com
(212) 709-8245

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/moore-kuehn-encourages-uscr-qts-cnst-and-esxb-investors-to-contact-law-firm-301308321.html

SOURCE Moore Kuehn, PLLC

Nachrichten zu Constellation Pharmaceuticals Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Constellation Pharmaceuticals Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!